Laboratory Corporation of America Holdings (LH) 129.62 $LH
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 226.16 (-4.53), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
Laboratory Corp of America Holdings Set to Possibly Pullback After Yesterday's Rally of 2.15%
Comtex SmarTrend(R) - Mon Jun 20, 4:07PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
After Yesterday's Rally of 2.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 20, 4:05PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
Align Technology Strong on Invisalign Growth; Currency Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 7:30AM CDT
On Jun 14, 2016, we issued an updated research report on California-based Align Technology Inc. (ALGN).
ALGN: 79.00 (-2.82), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
After Yesterday's Decline of 2.01%, Laboratory Corp of America Holdings Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jun 13, 1:55PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $127.36 to a high of $130.13. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.28 on volume of 530,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LH: 129.62 (-1.56)
SmarTrend Watching for Potential Rebound in Shares of Laboratory Corp of America Holdings After 2.01% Loss
Comtex SmarTrend(R) - Mon Jun 13, 1:54PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $127.36 to a high of $130.13. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.28 on volume of 530,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LH: 129.62 (-1.56)
VWR Corp's Balanced Growth Partly Offset by Weak Margins
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 5:31PM CDT
On Jun 8, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
VWR: 28.91 (-1.17), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
LabCorp is Scheduled to Present at the 36th Annual William Blair Growth Stock Conference
BusinessWire - Wed Jun 08, 3:15PM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced it will participate at the 36th Annual William Blair Growth Stock Conference. LabCorp's presentation is planned for Tuesday, June 14, 2016 at 3:50 PM (ET).
LH: 129.62 (-1.56)
Laboratory Corp of America Holdings Rises 1.13% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 2:06PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $129.28 to a high of $131.24. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.20 on volume of 442,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
Look for Shares of Laboratory Corp of America Holdings to Potentially Pullback after Yesterday's 1.13% Rise
Comtex SmarTrend(R) - Wed Jun 08, 2:05PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $129.28 to a high of $131.24. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.20 on volume of 442,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
LabCorp Announces the Availability of the RealStar(R) Zika Virus Test
BusinessWire - Mon Jun 06, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the RealStar(R) Zika Virus RT-PCR Kit U.S. from altona Diagnostics GmbH. The test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the qualitative detection of Zika virus RNA in serum or urine (collected alongside a patient-matched serum specimen). It is intended to be used to aid in the diagnosis of Zika virus infection in individuals meeting clinical and/or epidemiological criteria for infection risk established by the Centers for Disease Control and Prevention (CDC).
LH: 129.62 (-1.56)
One Year After Launch, BRCA Share(TM) Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
PR Newswire - Wed Jun 01, 7:11AM CDT
BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of these genes raise the risk of breast, ovarian and other cancers. The findings are to be presented today at the 6th International Biennial Meeting of Human Variome Project Consortium (HVP6) held at UNESCO headquarters in Paris.
DGX: 78.90 (-1.63), LH: 129.62 (-1.56)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 34.30 (-0.71), AIRM: 35.93 (-1.00), CNMD: 44.20 (-1.30), LH: 129.62 (-1.56)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 35.93 (-1.00), CNMD: 44.20 (-1.30), PDCO: 46.35 (-2.11), LH: 129.62 (-1.56)
New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer
BusinessWire - Thu May 19, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of the VENTANA PD-L1 (SP142) Assay as a complementary diagnostic for TECENTRIQ (atezolizumab), a new immunotherapy treatment for patients with urothelial cancer, the most common form of bladder cancer in the U.S. The test was developed by Roche Diagnostics and was approved on May 18, 2016 by the U.S. Food and Drug Administration (FDA) to identify patients who may benefit from treatment with Genentech's TECENTRIQ (atezolizumab). The availability of this important new test demonstrates LabCorp's commitment to provide world-class diagnostics to physicians and their patients.
LH: 129.62 (-1.56)
7 Best Stocks to Attract You with Sales Growth
Zacks Equity Research - Zacks Investment Research - Wed May 18, 12:56PM CDT
In simple terms, some sustained sales growth is necessary to support the bottom line.
HAS: 82.37 (-3.83), WEX: 86.54 (-5.06), NWL: 46.51 (-2.95), LH: 129.62 (-1.56), WSFS: 31.63 (-2.04), Y: 528.06 (-14.53), LPLA: 22.96 (-2.83)
LabCorp (LH) Posts Strong Q1; Covance Synergy Continues
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:07AM CDT
On May 16, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 226.16 (-4.53), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
Watch for Laboratory Corp of America Holdings to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Wed May 11, 2:42PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.67 to a high of $128.44. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $126.76 on volume of 305,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
LabCorp Announces the Launch of the Epi proColon(R) Test for Colorectal Cancer Screening
BusinessWire - Mon May 09, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the launch of Epi proColon(R), a blood-based test for colorectal cancer screening that was approved on April 13, 2016 for clinical use by the U.S. Food and Drug Administration (FDA). Epi proColon(R) is the first FDA-approved DNA based blood test for colorectal cancer. The test was developed by Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) and is available under a joint commercialization agreement with Polymedco, Inc. in North America. LabCorp, the world's leading healthcare diagnostics company, is the first laboratory in the U.S. to offer this FDA-approved, blood-based colorectal cancer screening test.
LH: 129.62 (-1.56)
LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 226.16 (-4.53), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
Laboratory Corp of America Holdings Set to Possibly Pullback After Yesterday's Rally of 2.15%
Comtex SmarTrend(R) - Mon Jun 20, 4:07PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
After Yesterday's Rally of 2.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 20, 4:05PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
Align Technology Strong on Invisalign Growth; Currency Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 7:30AM CDT
On Jun 14, 2016, we issued an updated research report on California-based Align Technology Inc. (ALGN).
ALGN: 79.00 (-2.82), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
After Yesterday's Decline of 2.01%, Laboratory Corp of America Holdings Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jun 13, 1:55PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $127.36 to a high of $130.13. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.28 on volume of 530,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LH: 129.62 (-1.56)
SmarTrend Watching for Potential Rebound in Shares of Laboratory Corp of America Holdings After 2.01% Loss
Comtex SmarTrend(R) - Mon Jun 13, 1:54PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $127.36 to a high of $130.13. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $129.28 on volume of 530,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
LH: 129.62 (-1.56)
VWR Corp's Balanced Growth Partly Offset by Weak Margins
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 5:31PM CDT
On Jun 8, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
VWR: 28.91 (-1.17), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
LabCorp is Scheduled to Present at the 36th Annual William Blair Growth Stock Conference
BusinessWire - Wed Jun 08, 3:15PM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced it will participate at the 36th Annual William Blair Growth Stock Conference. LabCorp's presentation is planned for Tuesday, June 14, 2016 at 3:50 PM (ET).
LH: 129.62 (-1.56)
Laboratory Corp of America Holdings Rises 1.13% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jun 08, 2:06PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $129.28 to a high of $131.24. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.20 on volume of 442,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
Look for Shares of Laboratory Corp of America Holdings to Potentially Pullback after Yesterday's 1.13% Rise
Comtex SmarTrend(R) - Wed Jun 08, 2:05PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $129.28 to a high of $131.24. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $130.20 on volume of 442,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
LabCorp Announces the Availability of the RealStar(R) Zika Virus Test
BusinessWire - Mon Jun 06, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the RealStar(R) Zika Virus RT-PCR Kit U.S. from altona Diagnostics GmbH. The test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the qualitative detection of Zika virus RNA in serum or urine (collected alongside a patient-matched serum specimen). It is intended to be used to aid in the diagnosis of Zika virus infection in individuals meeting clinical and/or epidemiological criteria for infection risk established by the Centers for Disease Control and Prevention (CDC).
LH: 129.62 (-1.56)
One Year After Launch, BRCA Share(TM) Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
PR Newswire - Wed Jun 01, 7:11AM CDT
BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of these genes raise the risk of breast, ovarian and other cancers. The findings are to be presented today at the 6th International Biennial Meeting of Human Variome Project Consortium (HVP6) held at UNESCO headquarters in Paris.
DGX: 78.90 (-1.63), LH: 129.62 (-1.56)
Veeva Systems (VEEV) Q1 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:26AM CDT
Notably, Veeva (VEEV) posted an average positive surprise of 15.98% over the last four quarters.
VEEV: 34.30 (-0.71), AIRM: 35.93 (-1.00), CNMD: 44.20 (-1.30), LH: 129.62 (-1.56)
Can Patterson Companies (PDCO) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:32AM CDT
Patterson Companies Inc. (PDCO) is set to announce fourth-quarter fiscal 2016 earnings on May 26.
AIRM: 35.93 (-1.00), CNMD: 44.20 (-1.30), PDCO: 46.35 (-2.11), LH: 129.62 (-1.56)
New Complementary Diagnostic Test Available from LabCorp for Treatment of Bladder Cancer
BusinessWire - Thu May 19, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of the VENTANA PD-L1 (SP142) Assay as a complementary diagnostic for TECENTRIQ (atezolizumab), a new immunotherapy treatment for patients with urothelial cancer, the most common form of bladder cancer in the U.S. The test was developed by Roche Diagnostics and was approved on May 18, 2016 by the U.S. Food and Drug Administration (FDA) to identify patients who may benefit from treatment with Genentech's TECENTRIQ (atezolizumab). The availability of this important new test demonstrates LabCorp's commitment to provide world-class diagnostics to physicians and their patients.
LH: 129.62 (-1.56)
7 Best Stocks to Attract You with Sales Growth
Zacks Equity Research - Zacks Investment Research - Wed May 18, 12:56PM CDT
In simple terms, some sustained sales growth is necessary to support the bottom line.
HAS: 82.37 (-3.83), WEX: 86.54 (-5.06), NWL: 46.51 (-2.95), LH: 129.62 (-1.56), WSFS: 31.63 (-2.04), Y: 528.06 (-14.53), LPLA: 22.96 (-2.83)
LabCorp (LH) Posts Strong Q1; Covance Synergy Continues
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:07AM CDT
On May 16, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 226.16 (-4.53), LH: 129.62 (-1.56), HSIC: 170.87 (-6.74), COO: 166.80 (+0.21)
Watch for Laboratory Corp of America Holdings to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Wed May 11, 2:42PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.67 to a high of $128.44. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $126.76 on volume of 305,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 129.62 (-1.56)
LabCorp Announces the Launch of the Epi proColon(R) Test for Colorectal Cancer Screening
BusinessWire - Mon May 09, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the launch of Epi proColon(R), a blood-based test for colorectal cancer screening that was approved on April 13, 2016 for clinical use by the U.S. Food and Drug Administration (FDA). Epi proColon(R) is the first FDA-approved DNA based blood test for colorectal cancer. The test was developed by Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) and is available under a joint commercialization agreement with Polymedco, Inc. in North America. LabCorp, the world's leading healthcare diagnostics company, is the first laboratory in the U.S. to offer this FDA-approved, blood-based colorectal cancer screening test.
LH: 129.62 (-1.56)
